XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Summary of Significant Accounting Policies (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Oct. 11, 2024
USD ($)
Jul. 19, 2024
USD ($)
Apr. 30, 2020
USD ($)
Sep. 30, 2023
USD ($)
$ / shares
shares
Nov. 30, 2022
USD ($)
Apr. 30, 2020
USD ($)
Sep. 30, 2024
USD ($)
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
Policies                        
Net Income (Loss)             $ (31,592,000) $ (109,030,000) $ (136,655,000) $ (356,770,000)    
Accumulated deficit             2,514,091,000   2,514,091,000   $ 2,377,436,000  
Cash, cash equivalents and restricted cash       $ 668,710,000     892,844,000 $ 668,710,000 892,844,000 $ 668,710,000 642,095,000 $ 466,091,000
Marketable securities             29,490,000   29,490,000   236,882,000  
Short-term Credit Line, outstanding balance             80,469,000   80,469,000   $ 80,402,000  
Collateral amount             150,000,000.0   150,000,000.0      
Remaining borrowing capacity             $ 20,000,000.0   $ 20,000,000.0      
Common stock, shares issued | shares             124,137,000   124,137,000   119,581,000  
Payment of offering expenses       400,000                
Proceeds from issuance of common stock       $ 235,800,000                
Convertible Notes                        
Policies                        
Outstanding principal balance   $ 287,500,000 $ 287,500,000     $ 287,500,000 $ 287,500,000   $ 287,500,000      
Per annum interest rate (as a percent)   2.25%       2.25%     2.25%      
Percentage of principal amount converted   100.00% 100.00%                  
Convertible to shares of common stock     7,411,704                  
Convertible Notes | Subsequent event                        
Policies                        
Convertible Notes Payable $ 287,400,000                      
Convertible to shares of common stock 7,500,000                      
Proceeds from notes payable $ 100,000                      
Line Of Credit-UBS                        
Policies                        
Short-term Credit Line, outstanding balance             80,400,000   $ 80,400,000      
Borrowings under credit facility         $ 30,000,000.0              
Collateral amount             150,000,000.0   150,000,000.0      
Remaining borrowing capacity             $ 20,000,000.0   $ 20,000,000.0      
Interest rate (as a percent)             5.66%   5.66%      
Equity offering                        
Policies                        
Common stock, shares issued | shares       4,550,000       4,550,000   4,550,000    
Stock issued (in dollars per share) | $ / shares       $ 55       $ 55   $ 55